[Dongcheng Pharmaceutical: Termination of spin-off of subsidiary Lannacheng to be listed on the main board of the Hong Kong Stock Exchange] On October 14, Dongcheng Pharmaceutical (002675.SZ) announced that based on changes in the external environment and its own development planning considerations, it has decided to terminate the spin-off of its subsidiary Lannacheng to be listed on the main board of the Hong Kong Stock Exchange and withdrew the relevant application documents. This matter has been reviewed and approved by the board of directors and does not need to be submitted to the shareholders' meeting for review. It will not have a significant adverse impact on the company's production and operations. The company promises not to plan any major asset restructuring (including spin-off and listing) within one month after termination.